The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Xalatan 50 micrograms/ml eye drops, solution

50 microgram(s)/millilitre Eye drops, solution

Pfizer Healthcare IrelandPA0822/140/001

Main Information

Trade NameXalatan 50 micrograms/ml eye drops, solution
Active SubstancesLatanoprost
Strength50 microgram(s)/millilitre
Dosage FormEye drops, solution
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/140/001

Group Information

ATC CodeS01EE Prostaglandin analogues1)
S01EE01 latanoprost

Status

Authorised/WithdrawnAuthorised
Licence Issued25/07/1997
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0096-152-045
Interchangeable List DocumentPDF of Interchangeable List
« Back